{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T18:08:42Z","timestamp":1778782122346,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012513","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Enfermedades Cardiovasculares","doi-asserted-by":"publisher","award":["RD12\/0042\/0047"],"award-info":[{"award-number":["RD12\/0042\/0047"]}],"id":[{"id":"10.13039\/501100012513","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS PI14\/01682"],"award-info":[{"award-number":["FIS PI14\/01682"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.ejim.2020.04.031","type":"journal-article","created":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T01:03:10Z","timestamp":1589850190000},"page":"91-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Use of intravenous iron in patients with iron deficiency and chronic heart failure: Real-world evidence"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8780-720X","authenticated-orcid":false,"given":"Jos\u00e9","family":"Gonzalez-Costello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Cainzos-Achirica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Lup\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Farr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Moliner-Borja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7916-1223","authenticated-orcid":false,"given":"Cristina","family":"Enjuanes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"de Antonio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carles","family":"D\u00edez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoni","family":"Bay\u00e9s-Genis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicol\u00e1s","family":"Manito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram\u00f3n","family":"Pujol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Comin-Colet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2020.04.031_bib0001","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","article-title":"Iron deficiency: an ominous sign in patients with systolic chronic heart failure","volume":"31","author":"Jankowska","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2020.04.031_bib0002","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ejhf.84","article-title":"The additive burden of iron deficiency in the cardiorenal-anaemia axis: scope of a problem and its consequences","volume":"16","author":"Klip","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2020.04.031_bib0003","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.recesp.2015.08.017","article-title":"Iron status in chronic heart failure: Impact on symptoms, functional class and submaximal exercise capacity","volume":"69","author":"Enjuanes","year":"2016","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.ejim.2020.04.031_bib0004","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/eurjhf\/hft083","article-title":"Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status","volume":"15","author":"Comin-Colet","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2020.04.031_bib0005","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2019-001012","article-title":"Iron deficiency in heart failure with preserved ejection fraction: a systematic review and meta-analysis","volume":"6","author":"Beale","year":"2019","journal-title":"Open Heart"},{"key":"10.1016\/j.ejim.2020.04.031_bib0006","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1001\/jama.2017.5427","article-title":"Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: The IRONOUT HF randomized clinical trial","volume":"317","author":"Lewis","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2020.04.031_bib0007","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.jacc.2007.07.029","article-title":"Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency","volume":"50","author":"Toblli","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2020.04.031_bib0008","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jacc.2007.09.036","article-title":"Effect of intravenous iron sucrose on exercise tolerance in anemic and non-anemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial","volume":"51","author":"Okonko","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2020.04.031_bib0009","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2020.04.031_bib0010","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2020.04.031_bib0011","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","article-title":"Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency","volume":"136","author":"Van Veldhuisen","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2020.04.031_bib0012","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2020.04.031_bib0013","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","article-title":"ACC\/AHA\/HFSA Focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America","volume":"70","author":"Yancy","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ejim.2020.04.031_bib0015","article-title":"Definition of iron deficiency based on the gold standard of bone marrow iron staining in heart failure patients","volume":"11","author":"Grote","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ejim.2020.04.031_bib0016","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/eurjhf\/hfp140","article-title":"Rationale and design of Ferinject assessment in patients with iron deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia","volume":"11","author":"Anker","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2020.04.031_bib0017","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/ejhf.1305","article-title":"Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice","volume":"20","author":"McDonagh","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2020.04.031_bib0018","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1523-1755.2004.00450.x","article-title":"Impact of epoetin alfa on clinical end points in patients with chronic renal failure: a meta-analysis","volume":"65","author":"Jones","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2020.04.031_bib0019","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1161\/CIRCHEARTFAILURE.111.960906","article-title":"Iron deficiency in community-dwelling US adults with self-reported heart failure in the National Health and Nutrition Examination Survey III. Prevalence and association with anaemia and inflammation","volume":"4","author":"Parikh","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ejim.2020.04.031_bib0020","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Costello J, Com\u00edn-Colet J, Lup\u00f3n J, et\u00a0al. Importance of iron deficiency in patients with chronic heart failure as a predictor of mortality and hospitalizations: insights from an observational cohort study. BMC Cardiovasc Disord18:206. doi:10.1186\/s12872-018-0942-x.","DOI":"10.1186\/s12872-018-0942-x"},{"key":"10.1016\/j.ejim.2020.04.031_bib0021","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/ejh.12963","article-title":"Prevalence and prognostic impact of anemia and iron deficiency in patients hospitalized in an internal medicine ward: The PRO-IRON study","volume":"99","author":"Fonseca","year":"2017","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ejim.2020.04.031_bib0022","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa1214865","article-title":"Treatment of anemia with darbepoetin alfa in systolic heart failure","volume":"368","author":"Swedberg","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2020.04.031_bib0023","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"the TREAT Investigators. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2020.04.031_bib0024","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/eurjhf\/hfq165","article-title":"Iron deficiency and anaemia in heart failure: understanding the FAIR-HF trial","volume":"12","author":"Gonz\u00e1lez-Costello","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2020.04.031_bib0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ehf2.12379","article-title":"Prevalence of underlying malignancies in iron-deficient heart failure","volume":"6","author":"Martens","year":"2019","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.ejim.2020.04.031_bib0026","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00392-018-1327-y","article-title":"Long-term effects of iron deficiency in patients with heart failure with or without anemia: the RAID-HF follow-up study","volume":"108","author":"Wienbergen","year":"2019","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.ejim.2020.04.031_bib0027","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/HCO.0000000000000511","article-title":"Iron overload cardiomyopathy: from diagnosis to management","volume":"33","author":"D\u00edez-L\u00f3pez","year":"2018","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.ejim.2020.04.031_bib0028","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ejhf.823","article-title":"Effects of ferric carboxymaltose on hospitalizations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis","volume":"20","author":"Anker","year":"2018","journal-title":"Eur J Heart Fail"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362052030145X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362052030145X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T17:14:00Z","timestamp":1778778840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095362052030145X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":27,"alternative-id":["S095362052030145X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2020.04.031","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of intravenous iron in patients with iron deficiency and chronic heart failure: Real-world evidence","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2020.04.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}